Hypertension worsened by commonly used prescription meds
May 6, 2021
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity for drug substitution.
Weight-related COVID-19 severity starts in normal BMI range, especially in young
May 4, 2021
Increases in BMI, beginning in normal ranges, show a linear link to severe COVID-19 outcomes, independent of obesity-related diseases in younger and Black patients.
Being overweight ups risk of severe COVID-19 in hospital
April 29, 2021
This research “adds to the known data on the associations between obesity and severe COVID-19 disease and extends these findings” to patients who are overweight and/or have diabetes.
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
April 2, 2021
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
ApoB may better predict mortality risk in statin-treated patients
March 24, 2021
In the study, measures of apoB and non-HDL cholesterol, but not LDL cholesterol, were associated with increased residual mortality and myocardial infarction risk.
High obesity rates in Southern states magnify COVID threats
March 19, 2021
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government efforts and heighten competition for scarce doses.
ColCORONA: More questions than answers for colchicine in COVID-19
February 11, 2021
Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer review.
Calcium burden drives CV risk whether coronary disease is obstructive or not
December 10, 2020
That future cardiovascular risk tracks closely with plaque burden, but not so much with whether the coronary disease is obstructive, may never have been so clearly illustrated.
GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit
November 13, 2020
Omecamtiv mecarbil safely met its primary efficacy endpoint in patients with heart failure with reduced ejection fraction in GALACTIC-HF, but with a modest effect.
First-of-its kind guideline on lipid monitoring in endocrine diseases
November 6, 2020
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond diabetes; the aim is to make lipid panel routine in assessment.